UK Stock Factors to Watch for January 24

UK Stock Factors to Watch for January 24

Jan 24 (Reuters) – Britain’s FTSE 100 Index (.FTSE) is expected to open 22 points lower on Monday at 7,472, according to financial bookmakers.

* Bridgepoint: Singapore’s Temasek has agreed to buy Element Materials Technology for nearly $7 billion from London-listed BridgePoint Group (BPTB.L), according to two sources familiar with the matter. Read more

* M&C Saatchi: AdvancedAdvT (ADVT.L) has made a new offer to acquire advertising giant M&C Saatchi (SAA.L), including a partial cash alternative for investors in the British group, Sky News reported on Sunday. Read more

Register now to get unlimited access to Reuters.com for free

Register

Unilever plc: A person familiar with the matter told Reuters on Sunday that Nelson Peltz’s activist hedge fund, Trian Partners, has created a stake in Unilever Plc, adding to pressure on the consumer goods maker. Read more

– Informa: Informa, the information and events services regulator (INF.L), is preparing for the auction process to sell clinical research data provider Citeline in a deal that could value the company as much as 1.2 billion pounds ($1.63 billion), sources familiar with the case said. . With the case to Reuters.

Vodafone: Telecom companies Vodafone (VOD.L) and Eliade are in talks to reach a deal in Italy that would combine their businesses in a bid to end fierce competition in the euro zone’s third-largest economy, according to people familiar with the matter. Read more

– BP: The United Steelworkers’ Federation said on Friday that proposals from energy giant BP Plc would undermine its 56-year-old national program for contracts for refineries and chemical plants. Read more

See also  The ongoing side effects of COVID-19 are forcing patients to change their diet and lifestyles

* Shell: Shell said on Friday it had officially changed its name from Royal Dutch Shell Plc to Shell Plc (RDSa.L) as part of its plan to divest itself of its dual-share structure based from the Netherlands to Great Britain. Britain. Read more

*GSK: GlaxoSmithKline (GSK.L) and US partner Vir Biotechnology (VIR.O) will ramp up production of an antibody-based COVID-19 treatment by adding a second facility to meet growing demand in the United States. Read more

London’s FTSE 100 finished lower on Friday, dragged down by heavy mining and banking stocks, while tepid retail sales and interest rate hike expectations dampened investor sentiment. Read more

British Business Diaries:

* For more information on factors affecting European stocks, please click:

UK newspapers today > Financial Times > Other business headlines

Register now to get unlimited access to Reuters.com for free

Register

Sinchita Mitra-rapport gepresenteerd in Bengaluru

Our Standards: Thomson Reuters Trust Principles.

Leave a Reply

Your email address will not be published.